{
  "id": "metroticket_hcc",
  "title": "Metroticket Calculator for Hepatocellular Carcinoma (HCC) Survival",
  "description": "Predicts 3 and 5-year survival after liver transplantation for patients with hepatocellular carcinoma (HCC), especially those not meeting Milan Criteria. Uses tumor size, number, and vascular invasion status.",
  "category": "oncology",
  "version": "2009",
  "parameters": [
    {
      "name": "largest_nodule_size",
      "type": "integer",
      "required": true,
      "description": "Size of the largest vital tumor nodule in millimeters",
      "validation": {
        "min": 0,
        "max": 99
      },
      "unit": "mm"
    },
    {
      "name": "number_of_nodules",
      "type": "integer",
      "required": true,
      "description": "Number of vital tumor nodules (≥1cm)",
      "validation": {
        "min": 0,
        "max": 10
      },
      "unit": "nodules"
    },
    {
      "name": "vascular_invasion",
      "type": "string",
      "required": true,
      "description": "Presence or absence of vascular invasion",
      "options": ["unknown", "absent", "present"],
      "validation": {
        "enum": ["unknown", "absent", "present"]
      }
    }
  ],
  "result": {
    "name": "survival_prediction",
    "type": "object",
    "unit": "",
    "description": "Predicted 3-year and 5-year survival rates after liver transplantation"
  },
  "interpretation": {
    "ranges": [
      {
        "min": 0,
        "max": 7,
        "stage": "Within Up-to-Seven Criteria",
        "description": "Sum of size (cm) + number ≤7, no vascular invasion",
        "interpretation": "Excellent prognosis with 5-year survival rate of approximately 71.2%. These patients have outcomes comparable to those within Milan criteria and are good candidates for liver transplantation."
      },
      {
        "min": 7,
        "max": 999,
        "stage": "Beyond Up-to-Seven Criteria",
        "description": "Sum of size (cm) + number >7 or vascular invasion present",
        "interpretation": "Lower survival rates compared to up-to-seven criteria. Individual survival prediction varies based on specific tumor characteristics. Consider multidisciplinary evaluation for transplant candidacy."
      }
    ]
  },
  "references": [
    "Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009 Jan;10(1):35-43.",
    "Mazzaferro V, Sposito C, Zhou J, et al. Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma. Gastroenterology. 2018 Jan;154(1):128-139.",
    "Lei JY, Wang WT, Yan LN. \"Metroticket\" predictor for assessing liver transplantation to treat hepatocellular carcinoma: a single-center analysis in mainland China. World J Gastroenterol. 2013 Nov 28;19(44):8093-8."
  ],
  "formula": "Up-to-Seven: Sum of largest tumor diameter (cm) + number of tumors ≤7. Survival prediction based on tumor characteristics matrix.",
  "notes": [
    "Developed from 1,556 patients who underwent liver transplantation for HCC in 36 European centers",
    "The 'up-to-seven' criteria applies only in absence of macrovascular invasion",
    "Provides individualized survival predictions rather than dichotomous in/out criteria",
    "Less widely validated than original Milan criteria",
    "Metroticket 2.0 also incorporates AFP levels for improved prediction",
    "Online calculator available at http://www.hcc-olt-metroticket.org/"
  ]
}